Tuesday, October 13, 2020

Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern


By BY KATHERINE J. WU AND KATIE THOMAS from NYT Health https://ift.tt/31lgGsv
Clinical Trials, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), your-feed-healthcare

0 komentar

Post a Comment